EU Gives Green Light to Canagliflozin for DiabetesEU Gives Green Light to Canagliflozin for Diabetes

Canagliflozin is soon to become the second SGLT-2 inhibitor approved for the treatment of type 2 diabetes in the European Union, having received EMA endorsement yesterday. International Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news